[HTML][HTML] The use and impact of cognitive enhancers among university students: a systematic review

S Sharif, A Guirguis, S Fergus, F Schifano - Brain sciences, 2021 - mdpi.com
Introduction: Cognitive enhancers (CEs), also known as “smart drugs”,“study aids” or
“nootropics” are a cause of concern. Recent research studies investigated the use of CEs …

An updated review on synthetic cathinones

J Soares, VM Costa, ML Bastos, F Carvalho… - Archives of …, 2021 - Springer
Cathinone, the main psychoactive compound found in the plant Catha edulis Forsk.(khat), is
a β-keto analogue of amphetamine, sharing not only the phenethylamine structure, but also …

Substance-related exogenous psychosis: a postmodern syndrome

G Martinotti, L De Risio, C Vannini, F Schifano… - CNS …, 2021 - cambridge.org
There is growing recognition that substance use is associated with the emergence of
psychosis. Elements of post-modernity dominate contemporary social contexts and operate …

[HTML][HTML] A review of synthetic cathinones emerging in recent years (2019–2022)

P Kuropka, M Zawadzki, P Szpot - Forensic toxicology, 2023 - Springer
Purpose The emergence of novel psychoactive substances (NPS) has been being a
continuous and evolving problem for more than a decade. Every year, dozens of new …

[HTML][HTML] Synthetic cathinones and neurotoxicity risks: a systematic review

G Daziani, AF Lo Faro, V Montana, G Goteri… - International Journal of …, 2023 - mdpi.com
According to the EU Early Warning System (EWS), synthetic cathinones (SCs) are the
second largest new psychoactive substances (NPS) class, with 162 synthetic cathinones …

[HTML][HTML] A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative …

M Solmi, C Chen, C Daure, A Buot, M Ljuslin… - European …, 2022 - Elsevier
A scientometric analysis was realized to outline clinical research on psychedelics over the
last century. Web of Science Core Collection was searched up to March 18, 2022, for …

Atypical antipsychotic drugs in dual disorders: current evidence for clinical practice

G Martinotti, S Chiappini, A Mosca… - Current …, 2022 - ingentaconnect.com
Background: Concurrent disorder or dual diagnosis refers to a combination of substance use
disorders and mental disorders that occur in the same patient simultaneously. These …

The clinical challenges of synthetic cathinones

F Schifano, F Napoletano, D Arillotta… - British journal of …, 2020 - Wiley Online Library
Aims Within the new psychoactive substances (NPS) scenario, several hundred different
molecules, mostly including synthetic cannabinoids and cathinones, have been identified so …

[HTML][HTML] Identifying new/emerging psychoactive substances at the time of COVID-19; a web-based approach

V Catalani, D Arillotta, JM Corkery, A Guirguis… - Frontiers in …, 2021 - frontiersin.org
COVID-19-related disruptions of people and goods' circulation can affect drug markets,
especially for new psychoactive substances (NPSs). Drug shortages could cause a change …

New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review

F Schifano, S Chiappini, A Miuli, JM Corkery… - Experimental …, 2021 - Elsevier
The use of several new psychoactive substances (NPS) has become very popular and is
posing global health risks. Chemically and pharmacologically diverse molecules are …